Radiopharm Theranostics Limited (ASX:RAD) Insider Ian Turner Acquires 1,300,000 Shares

Radiopharm Theranostics Limited (ASX:RAD) insider Ian Turner acquired 1,300,000 shares of the business’s stock in a transaction on Wednesday, February 19th. The stock was acquired at an average cost of A$0.03 ($0.02) per share, with a total value of A$33,800.00 ($21,125.00).

Radiopharm Theranostics Stock Performance

The firm has a market cap of $60.78 million, a PE ratio of -0.19 and a beta of 0.82.

Radiopharm Theranostics Company Profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.